SC 13D Filing

Company

Cocrystal Pharma, Inc.

Filed

December 5, 2014

Accession Number

0001415889-14-003817

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →